Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop
Gespeichert in:
| Veröffentlicht in: | Molecular psychiatry 2011-11, Vol.16 (11), p.1064-1066 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1066 |
|---|---|
| container_issue | 11 |
| container_start_page | 1064 |
| container_title | Molecular psychiatry |
| container_volume | 16 |
| creator | Valenzuela, M Bartrés-Faz, D Beg, F Fornito, A Merlo-Pich, E Müller, U Öngür, D Toga, A W Yücel, M |
| description | |
| doi_str_mv | 10.1038/mp.2011.62 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_900636727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A271884091</galeid><sourcerecordid>A271884091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-bef4e6253f573faf8d57912c7576831418eb994806ee5e18a792342e3cd7a4503</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhoMotq7e-AMk6IWg7JrPScYbWYpfULQXeh2ymTPb1JlkTDKV_nszbG1RVHKRQ85z3ryHF6HHlGwo4frVOG0YoXTTsDvomArVrKVU-m6tuWzXgmpxhB7kfEHI0pT30RGjDZOMk2M0fII5RT_avQ97bDOG0E3Rh5KxD9gNPnhnB1ySt0N-jbcJ8A_A5RxqcQXlDT6DlCdwxV8C7lMclx7ufcoFn6V4CcHViZi-5fM4PUT3-ioDj67vFfr67u2Xkw_r08_vP55sT9dONKqsd9ALqAZ5LxXvba87qVrKnJKq0ZzWhWDXtkKTBkAC1Va1jAsG3HXKCkn4Cj0_6E4pfp8hFzP67GAYbIA4Z9MS0vBGMVXJp3-QF3FOoZpbIKqlrNIr9OxfEGtENdUyqW6pvR3A-NDHkqxbPjZbpqjWgrS0Upu_UPV0MHoXA_S-vv828OIw4FLMOUFvplTjSleGErPEb8bJLPGbZnH65NrpvBuhu0F_5V2Blwcg11bYQ7pd5X9ywZY5wY3cOC1EBX4CV8vAPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2645769257</pqid></control><display><type>article</type><title>Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Valenzuela, M ; Bartrés-Faz, D ; Beg, F ; Fornito, A ; Merlo-Pich, E ; Müller, U ; Öngür, D ; Toga, A W ; Yücel, M</creator><creatorcontrib>Valenzuela, M ; Bartrés-Faz, D ; Beg, F ; Fornito, A ; Merlo-Pich, E ; Müller, U ; Öngür, D ; Toga, A W ; Yücel, M</creatorcontrib><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/mp.2011.62</identifier><identifier>PMID: 21625230</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/2779/109 ; 692/700/1421/65 ; Alzheimer's disease ; Behavioral Sciences ; Biological Psychology ; Brain - drug effects ; Brain - pathology ; Central Nervous System Agents - pharmacology ; Central Nervous System Agents - therapeutic use ; Clinical trials ; Clinical Trials as Topic - methods ; Conferences, meetings and seminars ; Drug Discovery ; Endpoint Determination ; Genomes ; Humans ; Magnetic resonance imaging ; Medical imaging ; Medicine ; Medicine & Public Health ; Neuroimaging ; Neurosciences ; news-and-commentary ; Organ Size ; Patients ; Pharmacotherapy ; Physiology ; Power ; Precision Medicine ; Psychiatry ; Spectrum analysis ; Treatment Outcome</subject><ispartof>Molecular psychiatry, 2011-11, Vol.16 (11), p.1064-1066</ispartof><rights>Macmillan Publishers Limited 2011</rights><rights>COPYRIGHT 2011 Nature Publishing Group</rights><rights>Macmillan Publishers Limited 2011.</rights><rights>Copyright Nature Publishing Group Nov 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-bef4e6253f573faf8d57912c7576831418eb994806ee5e18a792342e3cd7a4503</citedby><cites>FETCH-LOGICAL-c467t-bef4e6253f573faf8d57912c7576831418eb994806ee5e18a792342e3cd7a4503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>310,311,315,781,785,790,791,23935,23936,25145,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21625230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Valenzuela, M</creatorcontrib><creatorcontrib>Bartrés-Faz, D</creatorcontrib><creatorcontrib>Beg, F</creatorcontrib><creatorcontrib>Fornito, A</creatorcontrib><creatorcontrib>Merlo-Pich, E</creatorcontrib><creatorcontrib>Müller, U</creatorcontrib><creatorcontrib>Öngür, D</creatorcontrib><creatorcontrib>Toga, A W</creatorcontrib><creatorcontrib>Yücel, M</creatorcontrib><title>Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><subject>692/308/2779/109</subject><subject>692/700/1421/65</subject><subject>Alzheimer's disease</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Brain - drug effects</subject><subject>Brain - pathology</subject><subject>Central Nervous System Agents - pharmacology</subject><subject>Central Nervous System Agents - therapeutic use</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic - methods</subject><subject>Conferences, meetings and seminars</subject><subject>Drug Discovery</subject><subject>Endpoint Determination</subject><subject>Genomes</subject><subject>Humans</subject><subject>Magnetic resonance imaging</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neuroimaging</subject><subject>Neurosciences</subject><subject>news-and-commentary</subject><subject>Organ Size</subject><subject>Patients</subject><subject>Pharmacotherapy</subject><subject>Physiology</subject><subject>Power</subject><subject>Precision Medicine</subject><subject>Psychiatry</subject><subject>Spectrum analysis</subject><subject>Treatment Outcome</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kV1rFDEUhoMotq7e-AMk6IWg7JrPScYbWYpfULQXeh2ymTPb1JlkTDKV_nszbG1RVHKRQ85z3ryHF6HHlGwo4frVOG0YoXTTsDvomArVrKVU-m6tuWzXgmpxhB7kfEHI0pT30RGjDZOMk2M0fII5RT_avQ97bDOG0E3Rh5KxD9gNPnhnB1ySt0N-jbcJ8A_A5RxqcQXlDT6DlCdwxV8C7lMclx7ufcoFn6V4CcHViZi-5fM4PUT3-ioDj67vFfr67u2Xkw_r08_vP55sT9dONKqsd9ALqAZ5LxXvba87qVrKnJKq0ZzWhWDXtkKTBkAC1Va1jAsG3HXKCkn4Cj0_6E4pfp8hFzP67GAYbIA4Z9MS0vBGMVXJp3-QF3FOoZpbIKqlrNIr9OxfEGtENdUyqW6pvR3A-NDHkqxbPjZbpqjWgrS0Upu_UPV0MHoXA_S-vv828OIw4FLMOUFvplTjSleGErPEb8bJLPGbZnH65NrpvBuhu0F_5V2Blwcg11bYQ7pd5X9ywZY5wY3cOC1EBX4CV8vAPA</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Valenzuela, M</creator><creator>Bartrés-Faz, D</creator><creator>Beg, F</creator><creator>Fornito, A</creator><creator>Merlo-Pich, E</creator><creator>Müller, U</creator><creator>Öngür, D</creator><creator>Toga, A W</creator><creator>Yücel, M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop</title><author>Valenzuela, M ; Bartrés-Faz, D ; Beg, F ; Fornito, A ; Merlo-Pich, E ; Müller, U ; Öngür, D ; Toga, A W ; Yücel, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-bef4e6253f573faf8d57912c7576831418eb994806ee5e18a792342e3cd7a4503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>692/308/2779/109</topic><topic>692/700/1421/65</topic><topic>Alzheimer's disease</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Brain - drug effects</topic><topic>Brain - pathology</topic><topic>Central Nervous System Agents - pharmacology</topic><topic>Central Nervous System Agents - therapeutic use</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic - methods</topic><topic>Conferences, meetings and seminars</topic><topic>Drug Discovery</topic><topic>Endpoint Determination</topic><topic>Genomes</topic><topic>Humans</topic><topic>Magnetic resonance imaging</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neuroimaging</topic><topic>Neurosciences</topic><topic>news-and-commentary</topic><topic>Organ Size</topic><topic>Patients</topic><topic>Pharmacotherapy</topic><topic>Physiology</topic><topic>Power</topic><topic>Precision Medicine</topic><topic>Psychiatry</topic><topic>Spectrum analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valenzuela, M</creatorcontrib><creatorcontrib>Bartrés-Faz, D</creatorcontrib><creatorcontrib>Beg, F</creatorcontrib><creatorcontrib>Fornito, A</creatorcontrib><creatorcontrib>Merlo-Pich, E</creatorcontrib><creatorcontrib>Müller, U</creatorcontrib><creatorcontrib>Öngür, D</creatorcontrib><creatorcontrib>Toga, A W</creatorcontrib><creatorcontrib>Yücel, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valenzuela, M</au><au>Bartrés-Faz, D</au><au>Beg, F</au><au>Fornito, A</au><au>Merlo-Pich, E</au><au>Müller, U</au><au>Öngür, D</au><au>Toga, A W</au><au>Yücel, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>16</volume><issue>11</issue><spage>1064</spage><epage>1066</epage><pages>1064-1066</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>21625230</pmid><doi>10.1038/mp.2011.62</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1359-4184 |
| ispartof | Molecular psychiatry, 2011-11, Vol.16 (11), p.1064-1066 |
| issn | 1359-4184 1476-5578 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_900636727 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | 692/308/2779/109 692/700/1421/65 Alzheimer's disease Behavioral Sciences Biological Psychology Brain - drug effects Brain - pathology Central Nervous System Agents - pharmacology Central Nervous System Agents - therapeutic use Clinical trials Clinical Trials as Topic - methods Conferences, meetings and seminars Drug Discovery Endpoint Determination Genomes Humans Magnetic resonance imaging Medical imaging Medicine Medicine & Public Health Neuroimaging Neurosciences news-and-commentary Organ Size Patients Pharmacotherapy Physiology Power Precision Medicine Psychiatry Spectrum analysis Treatment Outcome |
| title | Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T16%3A45%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroimaging%20as%20endpoints%20in%20clinical%20trials:%20Are%20we%20there%20yet?%20Perspective%20from%20the%20first%20Provence%20workshop&rft.jtitle=Molecular%20psychiatry&rft.au=Valenzuela,%20M&rft.date=2011-11-01&rft.volume=16&rft.issue=11&rft.spage=1064&rft.epage=1066&rft.pages=1064-1066&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/mp.2011.62&rft_dat=%3Cgale_proqu%3EA271884091%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2645769257&rft_id=info:pmid/21625230&rft_galeid=A271884091&rfr_iscdi=true |